共 92 条
[1]
Spiegel B(2009)Psychometric evaluation of patient-reported outcomes in irritable bowel syndrome randomized controlled trials: A Rome Foundation report Gastroenterology 137 1944-1953
[2]
Camilleri M(1999)Psychometric validation of a constipation symptom assessment questionnaire Scandinavian Journal of Gastroenterology 348 70-77
[3]
Bolus R(2014)Effect of prucalopride on symptoms of chronic constipation Neurogastroenterology and Motility 1 21-27
[4]
Andresen V(2008)A placebo-controlled trial of prucalopride for severe chronic constipation New England Journal of Medicine 358 2344-2354
[5]
Chey WD(2009)Clinical trial: The efficacy, impact on quality of life, and safety and tolerability of prucalopride in severe chronic constipation—A 12-week, randomized, double-blind, placebo-controlled study Alimentary Pharmacology and Therapeutics 29 315-328
[6]
Fehnel S(2009)Prucalopride (Resolor) in the treatment of severe chronic constipation in patients dissatisfied with laxatives Gut 58 357-365
[7]
Frank L(2006)Validation of the PAC-SYM questionnaire for opioid-induced constipation in patients with chronic low back pain European Journal of Pain 10 209-217
[8]
Kleinman L(2006)Functional bowel disorders Gastroenterology 130 1480-1491
[9]
Farup C(2010)Inability of the Rome III criteria to distinguish functional constipation from constipation-subtype irritable bowel syndrome American Journal of Gastroenterology 105 2228-2234
[10]
Taylor L(2005)Hierarchical construct validity of the treatment satisfaction questionnaire for medication (TSQM version II among outpatient pharmacy consumers Value Health 8 S9-S24